LQDA Stock Analysis: Buy, Sell, or Hold?
LQDA - Liquidia Corporation Common Stock
$42.39
-0.67 (-1.56%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 18, 2026
Get Alerted When LQDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called LQDA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LQDA is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: LQDA is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$55.87
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$34.69
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LQDA is currently trading at $42.39, which is considered extended relative to its 30-day fair value range of $33.28 to $40.94. The stock's valuation (Forward PE: 16.0) is in line with its historical norms (14.8). At these levels, the market is pricing in 2.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LQDA is in a strong uptrend. Immediate support is located at $36.28, while resistance sits at $44.27.
Market Sentiment: LQDA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LQDA is in a strong uptrend. Immediate support is located at $36.28, while resistance sits at $44.27.
Market Sentiment: LQDA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$33.28 -
$40.94
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding LQDA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($43.00)
- NEUTRAL: Market pricing in 2.6% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$33.28 -
$40.94
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$36.28
Resistance Level
$44.27
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
15.98
Wall Street Target
$43.00
(-0.1%)
Revenue Growth (YoY)
1121.7%
Profit Margin
-179.3%
Valuation Premium vs History
+2.6% premium
PE vs Historical
16.0 vs 14.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.6%
(market-implied from PE analysis)
1-Year Target
$44.18
(+3%)
2-Year Target
$45.33
(+5%)
3-Year Target
$46.51
(+8%)
3-Yr Target (if PE normalizes)
(PE: 16→15)
PE COMPRESSION
$43.06
(0%)
Earnings growth offset by PE compression
Last updated: January 30, 2026 10:04 PM ET
Data refreshes hourly during market hours. Next update: 11:04 PM
Data refreshes hourly during market hours. Next update: 11:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LQDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason Adair
SELL
3670 shares
2025-10-13
Michael Kaseta
SELL
11630 shares
2025-10-13
Rajeev Saggar
SELL
5327 shares
2025-10-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced LQDA Option Strategies
Professional options setups generated by AI based on today's LQDA price and gamma walls.